izvor podataka: crosbi
!
Use of bisphosphonates in combination with sunitinib in renal cell cancer patients with bone metastases from the Expanded Access Study (CROSBI ID 616612)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Vrdoljak, E ; Szczylik, S ; Mardiak, J ; Stella, A ; Kharkevich, G ; Leyman, S ; Zhang, K ; Torday, L ;
Use of bisphosphonates in combination with sunitinib in renal cell cancer patients with bone metastases from the Expanded Access Study. 2013
Podaci o odgovornosti
Vrdoljak, E ; Szczylik, S ; Mardiak, J ; Stella, A ; Kharkevich, G ; Leyman, S ; Zhang, K ; Torday, L ;
engleski
Use of bisphosphonates in combination with sunitinib in renal cell cancer patients with bone metastases from the Expanded Access Study
Use of bisphosphonates in combination with sunitinib in renal cell cancer patients with bone metastases from the Expanded Access Study
renal cell cancer
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2013.
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
ESMO_ECCO 2013
poster
27.09.2013-01.10.2013
Amsterdam, Nizozemska
Povezanost rada
Povezane osobe
Povezane ustanove
